Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial.
The Lancet Oncology.
Times cited: 24
Cancer therapy-induced cardiac toxicity in early breast cancer addressing the unresolved issues.
Times cited: 115
A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer.
JAMA - Journal of the American Medical Association.
Times cited: 323
Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005.
Annals of Oncology.
Times cited: 886